v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2026
Jul. 31, 2025
Current assets:    
Cash and cash equivalents $ 982,112 $ 2,389,023
Short-term investments 2,556,995 1,183,386
Accounts receivable, net 730,461 992,181
Deferred contract acquisition costs 196,706 180,819
Prepaid expenses and other current assets 187,911 148,881
Total current assets 4,654,185 4,894,290
Property and equipment, net 574,737 543,377
Operating lease right-of-use assets 138,186 89,772
Deferred contract acquisition costs, noncurrent 347,820 328,722
Acquired intangible assets, net 191,735 47,323
Goodwill 1,094,434 417,730
Other noncurrent assets 96,982 98,674
Total assets 7,098,079 6,419,888
Current liabilities:    
Accounts payable 33,874 46,906
Accrued expenses and other current liabilities 122,577 93,984
Accrued compensation 180,637 181,807
Deferred revenue 2,097,103 2,054,417
Operating lease liabilities 66,751 52,497
Total current liabilities 2,500,942 2,429,611
Convertible senior notes 1,699,636 1,700,727
Deferred revenue, noncurrent 380,063 413,609
Operating lease liabilities, noncurrent 94,797 43,352
Other noncurrent liabilities 56,046 33,316
Total liabilities 4,731,484 4,620,615
Commitments and contingencies (Note 12)
Stockholders’ Equity    
Preferred stock; $0.001 par value; 200,000 shares authorized as of April 30, 2026 and July 31, 2025; no shares issued and outstanding as of April 30, 2026 and July 31, 2025 0 0
Common stock; $0.001 par value; 1,000,000 shares authorized as of April 30, 2026 and July 31, 2025; 161,710 and 158,301 shares issued and outstanding as of April 30, 2026 and July 31, 2025, respectively 162 159
Additional paid-in capital 3,623,519 2,980,591
Accumulated other comprehensive income (loss) (7,718) 8,081
Accumulated deficit (1,249,368) (1,189,558)
Total stockholders’ equity 2,366,595 1,799,273
Total liabilities and stockholders’ equity $ 7,098,079 $ 6,419,888